Effects of Antidepressants on Insulin Resistance in Major Depressive Disorder: A Systematic Review
This systematic review evaluates how different antidepressant classes affect insulin resistance, a metabolic complication common in depression. Tricyclic antidepressants (nortriptyline, amitriptyline, imipramine) worsen insulin sensitivity, while SSRIs and SNRIs appear metabolically neutral; bupropion and agomelatine show potential metabolic benefits in diabetic patients.